Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer

Gastric/gastroesophageal junction (G/GEJ) cancer represents a significant global health challenge. Radical surgery remains the cornerstone of treatment for resectable G/GEJ cancer. Supported by robust evidence from multiple clinical studies, therapeutic approaches, including adjuvant chemotherapy or...

Descripció completa

Dades bibliogràfiques

Autors principals:	Feizhi Lin, Yongming Chen, Bowen Huang, Shenghang Ruan, Jun Lin, Zewei Chen, Chunyu Huang, Baiwei Zhao
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-05-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	perioperative treatment gastric cancer immunotherapy neoadjuvant therapy adjuvant therapy chemotherapy
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1391562/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!